Skip to Content

WATSON 698 200 (Hydroxychloroquine Sulfate 200 mg)

Pill with imprint WATSON 698 200 is White, Elliptical / Oval and has been identified as Hydroxychloroquine Sulfate 200 mg. It is supplied by Actavis Pharma, Inc..

Hydroxychloroquine is used in the treatment of rheumatoid arthritis; systemic lupus erythematosus; lyme disease, arthritis; dermatomyositis; malaria (and more), and belongs to the drug classes antimalarial quinolines, antirheumatics. FDA has not classified the drug for risk during pregnancy. Hydroxychloroquine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 698 200

Hydroxychloroquine sulfate 200 mg WATSON 698 200
Hydroxychloroquine sulfate 200 mg WATSON 698 200
Hydroxychloroquine sulfate 200 mg WATSON 698 200

Hydroxychloroquine Sulfate

Imprint:
WATSON 698 200
Strength:
200 mg
Color:
White
Size:
13.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antimalarial quinolines
Antirheumatics
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
Inactive Ingredients:
silicon dioxide
dextrates
magnesium stearate
maltodextrin
microcrystalline cellulose
polydextrose
polyethylene glycol 8000
sodium starch glycolate type A potato
corn starch
titanium dioxide
triacetin
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
hypromellose 2910 (50 mPa.s)
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00591-0698 Watson Pharmaceuticals, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide